Rebecca Lynn Weintraub, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| General Practice | 1 | 2022 | 96 | 0.770 |
Why?
|
| Immunization Programs | 1 | 2020 | 268 | 0.590 |
Why?
|
| Schools, Medical | 2 | 2024 | 878 | 0.560 |
Why?
|
| Delivery of Health Care | 3 | 2020 | 5332 | 0.440 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 1172 | 0.430 |
Why?
|
| Health Resources | 1 | 2019 | 935 | 0.430 |
Why?
|
| Hospitals, University | 1 | 2011 | 564 | 0.330 |
Why?
|
| Education, Medical | 1 | 2019 | 1726 | 0.290 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 726 | 0.260 |
Why?
|
| Universities | 1 | 2011 | 993 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1403 | 0.250 |
Why?
|
| Ileal Neoplasms | 1 | 2004 | 20 | 0.230 |
Why?
|
| Medical Assistance | 1 | 2023 | 108 | 0.200 |
Why?
|
| Software | 1 | 2015 | 4426 | 0.190 |
Why?
|
| Public Health | 3 | 2023 | 2665 | 0.180 |
Why?
|
| Mass Vaccination | 1 | 2021 | 109 | 0.170 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4789 | 0.150 |
Why?
|
| Government Agencies | 1 | 2018 | 160 | 0.150 |
Why?
|
| Health Care Rationing | 1 | 2021 | 437 | 0.150 |
Why?
|
| Workflow | 1 | 2022 | 851 | 0.150 |
Why?
|
| Health Policy | 3 | 2021 | 2680 | 0.140 |
Why?
|
| Rwanda | 1 | 2019 | 665 | 0.140 |
Why?
|
| Pharmaceutical Services | 1 | 2018 | 141 | 0.140 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 27 | 0.120 |
Why?
|
| Vaccination | 3 | 2024 | 3375 | 0.120 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 5421 | 0.120 |
Why?
|
| Education, Graduate | 1 | 2015 | 75 | 0.120 |
Why?
|
| International Cooperation | 1 | 2021 | 1428 | 0.120 |
Why?
|
| Health Plan Implementation | 1 | 2015 | 337 | 0.100 |
Why?
|
| Problem-Based Learning | 1 | 2015 | 353 | 0.100 |
Why?
|
| Uganda | 1 | 2015 | 1332 | 0.090 |
Why?
|
| Organizations | 1 | 2011 | 171 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2015 | 1191 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2022 | 41366 | 0.080 |
Why?
|
| Models, Organizational | 1 | 2011 | 546 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3685 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7817 | 0.070 |
Why?
|
| HIV Infections | 1 | 2013 | 17328 | 0.070 |
Why?
|
| Humans | 17 | 2024 | 760437 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2004 | 5143 | 0.060 |
Why?
|
| Hospitals, Municipal | 1 | 2005 | 19 | 0.060 |
Why?
|
| Health Education | 1 | 2011 | 1052 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2003 | 44 | 0.060 |
Why?
|
| Plasminogen | 1 | 2003 | 146 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8623 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2011 | 1127 | 0.050 |
Why?
|
| Africa | 1 | 2024 | 709 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1832 | 0.040 |
Why?
|
| Massachusetts | 1 | 2011 | 8826 | 0.040 |
Why?
|
| Patient Admission | 1 | 2005 | 1367 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 3996 | 0.030 |
Why?
|
| Pharmacists | 1 | 2018 | 259 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 54339 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 1385 | 0.030 |
Why?
|
| Monocytes | 1 | 2003 | 2572 | 0.030 |
Why?
|
| Inpatients | 1 | 2005 | 2545 | 0.030 |
Why?
|
| United States | 4 | 2024 | 72202 | 0.030 |
Why?
|
| Drug Industry | 1 | 2018 | 788 | 0.020 |
Why?
|
| Male | 4 | 2024 | 360035 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2018 | 1087 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1663 | 0.020 |
Why?
|
| Adult | 2 | 2022 | 220781 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 3344 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12969 | 0.020 |
Why?
|
| Macrophages | 1 | 2003 | 5764 | 0.020 |
Why?
|
| Female | 3 | 2024 | 391875 | 0.020 |
Why?
|
| San Francisco | 1 | 2005 | 162 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2005 | 249 | 0.010 |
Why?
|
| Thioglycolates | 1 | 2003 | 38 | 0.010 |
Why?
|
| Utilization Review | 1 | 2005 | 382 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 26063 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 21322 | 0.010 |
Why?
|
| Infant | 1 | 2024 | 36183 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2024 | 42209 | 0.010 |
Why?
|
| Housing | 1 | 2005 | 667 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1407 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 2425 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2003 | 1163 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 2683 | 0.010 |
Why?
|
| Child | 1 | 2024 | 80086 | 0.010 |
Why?
|
| Adolescent | 1 | 2024 | 88196 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 1725 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2005 | 2087 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4549 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 5198 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 168840 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 11526 | 0.000 |
Why?
|
| Middle Aged | 1 | 2005 | 220382 | 0.000 |
Why?
|